Curcumin and Cancer: Can It Supplement Chemotherapies for Cancers?
Men's Health Journal,
Vol. 4 No. 1 (2020),
19 April 2020
,
Page e25
https://doi.org/10.22037/mhj.v4i1.33250
Abstract
Abstract
Despite advances in knowledge and information on the causes of cancers, prevention, the excellence of diagnostic systems, and the great achievements of oncology, the incidence of cancer still seems to be on the rise. The used chemical medications, in turn, have shown numerous side effects and cellular toxicity. That is why researchers have always been looking for anti-cancer drugs without adverse effects on the patient. Hence, herbal medicines have received special attention. Curcumin (diferuloylmethane) has been used as a spice in many countries around the world, including Iran, for centuries. Countless properties of this substance, which is obtained from the plant's root, such as anti-inflammatory, anti-mutagenic, anti-cancer, anti-fungal have been reported. This substance is able to affect cell signaling through multiple biochemical pathways, proliferation, differentiation, and cell death. The purpose of writing this review was to examine curcumin and its anti-cancer properties in a general view for its use in practical medicine.
Curcumin, with its epigenetic changes in the level of chromatin, is effective in regulating the expression of major and regulatory genes and can play a cancer-preventing role in the cell. Also, this substance and its compounds with inhibition activity of viral protein ACE-2 and Spike glycoprotein of SARS-CoV-2, and regulation of innate immune response have shown several roles in the fight against diseases.
To better understand the mechanism of action of turmeric metabolites with stimulant or inhibitory properties, it is necessary to do more research on the particular effects of Curcumin on various diseases, including cancer, effective dose and how to use it alone or in combination with other drugs.
How to Cite
References
Organization WH. National policy on traditional medicine and regulation of herbal medicines: Report of a WHO global survey: World Health Organization; 2005.
Coghlan ML, Maker G, Crighton E, Haile J, Murray DC, White NE, et al. Combined DNA, toxicological and heavy metal analyses provides an auditing toolkit to improve pharmacovigilance of traditional Chinese medicine (TCM). Scientific reports. 2015;5:17475.
Pandey MM, Rastogi S, Rawat AK. Indian traditional ayurvedic system of medicine and nutritional supplementation. Evidence-based complementary and alternative medicine : eCAM. 2013;2013:376327.
Ernst E, Schmidt K, Wider B. CAM research in Britain: the last 10 years. Complementary therapies in clinical practice. 2005;11(1):17-20.
Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. National health statistics reports. 2008(12):1-23.
Tilburt JC, Kaptchuk TJ. Herbal medicine research and global health: an ethical analysis. Bulletin of the World Health Organization. 2008;86(8):594-9.
Li JW, Vederas JC. Drug discovery and natural products: end of an era or an endless frontier? Science (New York, NY). 2009;325(5937):161-5.
Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012;75(3):311-35.
Organization WH. WHO global report on traditional and complementary medicine 2019: World Health Organization; 2019.
Priyadarsini KI. The chemistry of curcumin: from extraction to therapeutic agent. Molecules. 2014;19(12):20091-112.
APA, National Center for Biotechnology Information (2020). PubChem Compound Summary for CID 969516 CRO, 2020 from https://pubchem.ncbi.nlm.nih.gov/compound/Curcumin.
Belcaro G, Cesarone M, Dugall M, Pellegrini L, Ledda A, Grossi M, et al. Product-evaluation registry of Meriva®, a curcumin-phosphatidylcholine complex, for the complementary management of osteoarthritis. Panminerva Med. 2010;52(2 Suppl 1):55-62.
Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. The essential medicinal chemistry of curcumin: miniperspective. Journal of medicinal chemistry. 2017;60(5):1620-37.
Singh P, Bhooshan Pandey K, Ibrahim Rizvi S. Curcumin: the yellow molecule with pleiotropic biological effects. Letters in Drug Design & Discovery. 2016;13(2):170-7.
Megraj KVK, Raju K, Balaraman R, Meenakshisundaram K. Biological activities of some Indian medicinal plants. Journal of Advanced Pharmacy Education & Research. 2011;1(1):12-44.
Shababdoust A, Ehsani M, Shokrollahi P, Zandi M. Fabrication of curcumin-loaded electrospun nanofiberous polyurethanes with anti-bacterial activity. Progress in biomaterials. 2018;7(1):23-33.
Mahmood K, Zia KM, Zuber M, Salman M, Anjum MN. Recent developments in curcumin and curcumin based polymeric materials for biomedical applications: A review. International journal of biological macromolecules. 2015;81:877-90.
Hewlings SJ, Kalman DS. Curcumin: A Review of Its' Effects on Human Health. Foods. 2017;6(10):92.
Scapagnini G, Colombrita C, Amadio M, D'Agata V, Arcelli E, Sapienza M, et al. Curcumin activates defensive genes and protects neurons against oxidative stress. Antioxidants & redox signaling. 2006;8(3-4):395-403.
Jamwal R. Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers. Journal of integrative medicine. 2018;16(6):367-74.
Stanić Z. Curcumin, a compound from natural sources, a true scientific challenge–a review. Plant Foods for Human Nutrition. 2017;72(1):1-12.
Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. European journal of cancer (Oxford, England : 1990). 2005;41(13):1955-68.
Tsuda T. Curcumin as a functional food-derived factor: degradation products, metabolites, bioactivity, and future perspectives. Food & function. 2018;9(2):705-14.
Holder GM, Plummer JL, Ryan AJ. The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica; the fate of foreign compounds in biological systems. 1978;8(12):761-8.
Wahlström B, Blennow G. A study on the fate of curcumin in the rat. Acta pharmacologica et toxicologica. 1978;43(2):86-92.
Shafabakhsh R, Pourhanifeh MH, Mirzaei HR, Sahebkar A, Asemi Z, Mirzaei H. Targeting regulatory T cells by curcumin: A potential for cancer immunotherapy. Pharmacological research. 2019;147:104353.
Parashar K, Sood S, Mehaidli A, Curran C, Vegh C, Nguyen C, et al. Evaluating the Anti-cancer Efficacy of a Synthetic Curcumin Analog on Human Melanoma Cells and Its Interaction with Standard Chemotherapeutics. Molecules. 2019;24(13):2483.
Tomeh MA, Hadianamrei R, Zhao X. A review of curcumin and its derivatives as anticancer agents. International journal of molecular sciences. 2019;20(5):1033.
Sun L-R, Zhou W, Zhang H-M, Guo Q-S, Yang W, Li B-J, et al. Modulation of Multiple Signaling Pathways of the Plant-Derived Natural Products in Cancer. Front Oncol. 2019;9:1153-.
Vallée A, Lecarpentier Y, Vallée J-N. Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway. Journal of Experimental & Clinical Cancer Research. 2019;38(1):323.
Wang M, Jiang S, Zhou L, Yu F, Ding H, Li P, et al. Potential mechanisms of action of curcumin for cancer prevention: focus on cellular signaling pathways and miRNAs. International Journal of Biological Sciences. 2019;15(6):1200.
He G, Mu T, Yuan Y, Yang W, Zhang Y, Chen Q, et al. Effects of notch signaling pathway in cervical cancer by curcumin mediated photodynamic therapy and its possible mechanisms in vitro and in vivo. Journal of Cancer. 2019;10(17):4114.
Yang J, Wang C, Zhang Z, Chen X, Jia Y, Wang B, et al. Curcumin inhibits the survival and metastasis of prostate cancer cells via the Notch‐1 signaling pathway. Apmis. 2017;125(2):134-40.
Wang M, Jiang S, Zhou L, Yu F, Ding H, Li P, et al. Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs. Int J Biol Sci. 2019;15(6):1200-14.
Hasima N, Aggarwal BB. Cancer-linked targets modulated by curcumin. Int J Biochem Mol Biol. 2012;3(4):328-51.
Fadus MC, Lau C, Bikhchandani J, Lynch HT. Curcumin: An age-old anti-inflammatory and anti-neoplastic agent. Journal of traditional and complementary medicine. 2017;7(3):339-46.
Kumar G, Farooqui M, Rao CV. Role of Dietary Cancer-Preventive Phytochemicals in Pancreatic Cancer Stem Cells. Curr Pharmacol Rep. 2018;4(4):326-35.
Ramachandran C, Rodriguez S, Ramachandran R, Raveendran Nair PK, Fonseca H, Khatib Z, et al. Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer research. 2005;25(5):3293-302.
Pesic M, Markovic JZ, Jankovic D, Kanazir S, Markovic ID, Rakic L, et al. Induced resistance in the human non small cell lung carcinoma (NCI-H460) cell line in vitro by anticancer drugs. Journal of chemotherapy (Florence, Italy). 2006;18(1):66-73.
Chiang I, Wang W-S, Liu H-C, Yang S-T, Tang N-Y, Chung J-G. Curcumin alters gene expression-associated DNA damage, cell cycle, cell survival and cell migration and invasion in NCI-H460 human lung cancer cells in vitro. Oncology reports. 2015;34(4):1853-74.
Gan L, Li C, Wang J, Guo X. Curcumin modulates the effect of histone modification on the expression of chemokines by type II alveolar epithelial cells in a rat COPD model. International journal of chronic obstructive pulmonary disease. 2016;11:2765-73.
Hassan F-U, Rehman MS-U, Khan MS, Ali MA, Javed A, Nawaz A, et al. Curcumin as an Alternative Epigenetic Modulator: Mechanism of Action and Potential Effects. Front Genet. 2019;10:514-.
Soflaei SS, Momtazi-Borojeni AA, Majeed M, Derosa G, Maffioli P, Sahebkar A. Curcumin: a natural pan-HDAC inhibitor in cancer. Current pharmaceutical design. 2018;24(2):123-9.
Marcu MG, Jung YJ, Lee S, Chung EJ, Lee MJ, Trepel J, et al. Curcumin is an inhibitor of p300 histone acetylatransferase. Medicinal chemistry (Shariqah (United Arab Emirates)). 2006;2(2):169-74.
Vincek AS, Patel J, Jaganathan A, Green A, Pierre-Louis V, Arora V, et al. Inhibitor of CBP Histone Acetyltransferase Downregulates p53 Activation and Facilitates Methylation at Lysine 27 on Histone H3. Molecules. 2018;23(8):1930.
Marcu MG, Jung Y-J, Lee S, Chung E-J, Lee M-J, Trepel J, et al. Curcumin is an inhibitor of p300 histone acetylatransferase. Medicinal chemistry. 2006;2(2):169-74.
Teiten MH, Dicato M, Diederich M. Curcumin as a regulator of epigenetic events. Molecular nutrition & food research. 2013;57(9):1619-29.
Link A, Balaguer F, Shen Y, Lozano JJ, Leung H-CE, Boland CR, et al. Curcumin modulates DNA methylation in colorectal cancer cells. PloS one. 2013;8(2):e57709.
Kadayifci FZ, Zheng S, Pan Y-X. Molecular mechanisms underlying the link between diet and DNA methylation. International journal of molecular sciences. 2018;19(12):4055.
Kong A-NT. Inflammation, oxidative stress, and cancer: dietary approaches for cancer prevention: CRC Press; 2013.
Fu S, Kurzrock R. Development of curcumin as an epigenetic agent. Cancer. 2010;116(20):4670-6.
Sharma V, Jha A, Kumar A, Bhatnagar A, Narayan G, Kaur I. Curcumin-mediated reversal of p15 gene promoter methylation: implication in anti-neoplastic action against acute lymphoid leukaemia cell line. Folia biologica. 2015;61(2):81.
Carlos-Reyes Á, López-González JS, Meneses-Flores M, Gallardo-Rincón D, Ruíz-García E, Marchat LA, et al. Dietary Compounds as Epigenetic Modulating Agents in Cancer. Front Genet. 2019;10(79).
Carlos-Reyes Á, López-González JS, Meneses-Flores M, Gallardo-Rincón D, Ruíz-García E, Marchat LA, et al. Dietary compounds as epigenetic modulating agents in cancer. Front Genet. 2019;10:79.
Hassan HE, Carlson S, Abdallah I, Buttolph T, Glass KC, Fandy TE. Curcumin and dimethoxycurcumin induced epigenetic changes in leukemia cells. Pharmaceutical research. 2015;32(3):863-75.
Hassan F-u, Rehman MS-u, Khan MS, Ali MA, Javed A, Nawaz A, et al. Curcumin as an alternative epigenetic modulator: Mechanism of action and potential effects. Front Genet. 2019;10:514.
Liu Y, Sun H, Makabel B, Cui Q, Li J, Su C, et al. The targeting of non‑coding RNAs by curcumin: Facts and hopes for cancer therapy. Oncology Reports. 2019;42(1):20-34.
Bashang H, Tamma S. The use of curcumin as an effective adjuvant to cancer therapy: A short review. Biotechnology and applied biochemistry. 2019.
Tan BL, Norhaizan ME. Curcumin Combination Chemotherapy: The Implication and Efficacy in Cancer. Molecules. 2019;24(14).
Lee H-Y, Kim S-W, Lee G-H, Choi M-K, Jung H-W, Kim Y-J, et al. Turmeric extract and its active compound, curcumin, protect against chronic CCl 4-induced liver damage by enhancing antioxidation. BMC complementary and alternative medicine. 2016;16(1):316.
Fan X, Zhang C, Liu D-b, Yan J, Liang H-p. The clinical applications of curcumin: current state and the future. Current pharmaceutical design. 2013;19(11):2011-31.
Farzaei MH, Zobeiri M, Parvizi F, El-Senduny FF, Marmouzi I, Coy-Barrera E, et al. Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective. Nutrients. 2018;10(7):855.
Rocha FAC, de Assis MR. Curcumin as a potential treatment for COVID‐19. Phytotherapy Research. 2020.
Maurya VK, Kumar S, Prasad AK, Bhatt ML, Saxena SK. Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor. VirusDisease. 2020:1-15.
Chen L, Hu C, Hood M, Zhang X, Zhang L, Kan J, et al. A Novel Combination of Vitamin C, Curcumin and Glycyrrhizic Acid Potentially Regulates Immune and Inflammatory Response Associated with Coronavirus Infections: A Perspective from System Biology Analysis. Nutrients. 2020;12(4):1193.
Kurniawansyah F, Quachie L, Mammucari R, Foster NR. Improving the dissolution properties of curcumin using dense gas antisolvent technology. International Journal of Pharmaceutics. 2017;521(1-2):239-48.
Thies C. Nanocapsules as delivery systems in the food, beverage and nutraceutical industries. Nanotechnology in the Food, Beverage and Nutraceutical Industries: Elsevier; 2012. p. 208-56.
- Abstract Viewed: 115 times
- pdf Downloaded: 78 times